| |
|
|
Confluent
Surgical Gains U.S. Approval to Initiate
DuraSeal™ Clinical Trial
Confluent Surgical, Inc. today announced that the U.S. Food and Drug
Administration (FDA) has granted full approval of the Investigational
Device Exemption (IDE) for the DuraSeal™ Dural Sealant System
clinical study. |
|
05/29/03
Read
More |
| |
|
| |
|
|
Confluent
Surgical Announces Clinical Results for Prevention
of CSF Leak at AANS Symposium - Study Reports
100% Intraoperative Success
Confluent Surgical, Inc. today announced results from their DuraSeal™ Dural
Sealant clinical trial at the American Association of Neurological
Surgeons symposium in San Diego, CA. |
|
04/26/03
Read
More |
| |
|
| |
|
|
Confluent
Surgical Completes Dural Sealant Clinical
Trial
Confluent Surgical, Inc. today announced that it has completed a
multi-center European clinical trial of their DuraSeal™ Dural
Sealant and Adhesion Barrier System. |
|
12/16/02
Read
More |
| |
|
| |
|
|
Boston
Business Journal 1060 Radio with Amar Sawhney
(Written Interview)
David Anthony, Boston Business Journal 1060 Radio and Amar S Sawhney,
Confluent Surgical, Inc. |
|
07/03/02
Read
More |
| |
|
| |
|
|
CONFLUENT
SURGICAL, INC. Raises $20 Million in Series-C
Financing
Confluent Surgical, Inc., today announced that it has completed a
$20 million Series C round of venture funding, led by Essex Woodlands
Health Ventures. |
|
06/25/02
Read
More |
| |
|
| |
|
|
Confluent
Surgical Announces First Procedure In U.S.
Trial For SprayGel™ Adhesion Barrier
Confluent Surgical, Inc., today announced
the commencement of its pivotal U.S.
trial for the SprayGel Adhesion Barrier
in Prevention of Pelvic Adhesions
In Laparoscopic Surgery, the PREVAIL
Study. |
|
06/17/02
Read
More |
| |
|
| |
|
|
CEOCast.com
Interview with Amar Sawhney
Gary Nash, CEOCast and Amar S Sawhney, Confluent Surgical, Inc. |
|
04/24/02
Read
More |
| |
|
| |
Significant
Clinical Result in the Treatment of Adhesions
with the SprayGel™ Adhesion Barrier
Confluent Surgical, Inc. announced today that the SprayGel Adhesion
Barrier, their flagship product, exceeded the clinical expectations
of a leading German gynecologic surgeon in the treatment of a patient
suffering from adhesion-related pain for twenty two years. |
|
04/24/02
Read
More |
| |
|
| |
Confluent
Surgical Initiates Dural Sealant Clinical
Trial
Confluent Surgical, Inc. today announced that it has begun a single
site clinical trial of a Synthetic Dural Sealant product in a major
European clinical center |
|
02/20/02
Read
More |
| |
|
| |
CE
Mark Approval For SprayGel™
Confluent Surgical, Inc. Receives CE Mark Approval For SprayGel™ Adhesion
Barrier System. |
|
11/12/01
Read
More |
| |
|
| |
European-Approved
Confluent SprayGel
Inhale Announces that Recently European-Approved Confluent SprayGel
Post-Operative Adhesion Product Uses PEG from Shearwater |
|
11/01/01
Read
More |
| |
|
| |
Todays
News
Confluent Surgical, Inc. Begins SprayGel™ Adhesion Barrier
System Clinical Trial
PRNewswire - Confluent Surgical Inc. announced today that the Company
has begun a clinical trial for the SprayGel™ Adhesion Barrier
System. |
|
11/30/00
Read
More |
| |
|
| |
Venture
Round, Nov 2000
CONFLUENT SURGICAL, INC. Raises $12 Million in Series-B Financing. |
|
11/30/00
Read
More |
| |
|
| |
New
Scientist, Oct 2000
There's a new way to avoid internal scars after surgery. |
|
10/28/00
Read
More |
| |
|
| |
BBC
News, Oct 2000
Gel 'heals wounds without scars'. |
|
10/26/00
Read
More |
| |
|
| |
Tech
Review
PROTOTYPE - Innovations From Every Area of Technology. |
|
02/01/00
Read
More |
| |
|
| |
StartUp
Confluent Surgical - Adhering to a focused product development strategy. |
|
01/01/00
Read
More |
| |
|
| |
GraySheet
Tenex Medical Investors Helps Hatch Device Start-Up Confluent Surgical. |
|
10/04/99
Read
More |
| |
|
| |
Venture
Round, Sept 1999
Supplies, Equipment, And Devices - In a private placement led by
Spray Venture Partners and Schroeder International Life Sciences. |
|
09/01/99
Read
More |
| |
|
| |
